查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲质谱和层析法诊断市场（按产品类型、泰国应用和国家划分）分析和预测（2024-2033 年）
市场调查报告书
商品编码
1650831

欧洲质谱和层析法诊断市场（按产品类型、泰国应用和国家划分）分析和预测（2024-2033 年）

Europe Mass Spectrometry and Chromatography in Diagnostics Market: Focus on Product Type, Application Type, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 76 Pages | 商品交期: 1-5个工作天内

价格

预计 2024 年欧洲诊断质谱和层析法分析市场价值将达到 2.24 亿美元。

预计 2024 年至 2033 年期间市场复合年增长率为 9.41%，2033 年达到 5.033 亿美元。欧洲分析和生命科学仪器产业严重依赖质谱（MS）和层析法市场。这些技术为化学和生物物质的分离、鑑定和定量提供了先进的技术，推动了医学、环境监测、诊断和食品安全等领域的进步。质谱法和层析法不单独使用，但通常整合到诊断工作流程中。例如，液相层析法质谱仪结合了质谱仪的质量分析能力和液相层析法的分离能力，使其成为复杂样品分析的理想选择。这种混合方法在临床环境中特别有益，因为患者样本的高通量分析对于提供指南诊断和治疗的深入见解至关重要。这些技术在欧洲的重要诊断应用包括维生素分析、荷尔蒙分析和其他需要精确分离和分析成分的测试。

主要市场统计数据
预测期 2024-2033
2024 年评估 2.24亿美元
2033 年预测 5.033亿美元
复合年增长率 9.41％

患者样本日益复杂以及对精准诊断的需求正在推动欧洲诊断质谱和层析法市场的快速发展。临床诊断、个人化医疗和生物标记的发现都依赖质谱 (MS) 和层析法技术。质谱（MS）和层析法技术为化学和生物物质的分离、鑑定和定量提供了先进的技术。

液相层析法质谱 (LC-MS) 等混合系统已成为现代诊断工作流程中不可或缺的一部分，因为它们能够对复杂的临床样本进行高通量、准确和可靠的分析。这些技术对于维生素、代谢物、荷尔蒙和生物标记的分析特别有用，可以早期发现疾病并制定个人化的治疗方案。

代谢体学和蛋白​​质组学的治疗改进也推动了市场的发展，因为它们有助于更好地进行疾病监测、筛检和治疗计划。生物标记识别和标靶治疗研究的不断增多，进一步刺激了对高性能诊断工具的需求。

此外，在监管支援、医疗保健基础设施加强和主导分析的推动下，质谱和层析法在诊断领域的应用正在整个欧洲不断扩大。随着这些技术变得越来越普及，预计它们将广泛应用于一系列临床应用，并支持欧洲诊断市场的持续扩张。

本报告研究了欧洲诊断市场的质谱和层析法，并概述了市场状况以及产品类型、应用区域、国家和参与市场的公司概况等趋势。

目录

执行摘要

第 1层析法。

  • 市场概况
  • 主要趋势
  • 主要趋势的机会评估
  • 产品基准
  • 监管状态

第二章 区域

  • 区域概况
  • 驱动因素与限制因素
  • 欧洲

3. 欧洲诊断质谱和层析法分析市场：竞争基准化分析和公司概况

  • 竞争格局
    • 伙伴关係、合作和业务扩展
    • 新服务
    • 合併和收购
    • 监管部门核准
  • 关键策略和发展
  • 企业竞赛矩阵
  • 企业市场占有率分析
  • 公司简介
    • Tecan Group Ltd.
    • Merck KGaA
    • Chromsystems Instruments & Chemicals GmbH.
    • RECIPE Chemicals + Instruments GmbH
    • SENTINEL CH. SpA

第四章调查方法

Product Code: BHL2515SS

Introduction to Europe Mass Spectrometry and Chromatography in Diagnostics Market

The Europe mass spectrometry and chromatography in diagnostics market was valued at $224.0 million in 2024 and is expected to reach $503.3 million by 2033, growing at a CAGR of 9.41% between 2024 and 2033. The analytical and life sciences instrumentation sector in Europe relies heavily on the mass spectrometry (MS) and chromatography markets. These technologies propel advancements in pharmaceuticals, environmental monitoring, diagnostics, and food safety, among other fields, by offering sophisticated techniques for the separation, identification, and quantification of chemical and biological substances. Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For instance, liquid chromatography-mass spectrometry is perfect for complex sample analysis because it combines the mass analysis capability of mass spectrometry with the separation power of liquid chromatography. In clinical settings, where high-throughput analysis of patient samples is crucial for offering thorough insights that guide diagnosis and treatment, this hybrid approach is especially beneficial. Important diagnostic uses for these technologies in Europe include vitamin profiling, hormone profiling, and other tests that require precise separation and analysis of components.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$224.0 Million
2033 Forecast$503.3 Million
CAGR9.41%

The growing complexity of patient samples and the growing need for precision diagnostics are driving the rapid evolution of the Europe mass spectrometry and chromatography in diagnostics market. Clinical diagnostics, personalized medicine, and the search for biomarkers all depend on mass spectrometry (MS) and chromatography technologies because they offer advanced techniques for the separation, identification, and quantification of chemical and biological materials.

Because they provide high-throughput, precise, and dependable analysis for complicated clinical samples, hybrid systems like liquid chromatography-mass spectrometry (LC-MS) have become essential to contemporary diagnostic workflows. These technologies are especially useful for analyzing vitamins, metabolites, hormones, and biomarkers, which allows for early disease detection and individualized treatment plans.

Improvements in metabolomics and proteomics are also driving the market since they are facilitating better disease monitoring, screening, and treatment planning. The need for high-performance diagnostic tools is being further stimulated by growing research into biomarker identification and targeted therapies.

Furthermore, the use of mass spectrometry and chromatography in diagnostics is expanding throughout Europe due to regulatory support, enhanced healthcare infrastructure, and the incorporation of AI-driven analytics. The use of these technologies is anticipated to spread across a variety of clinical applications as they become more widely available, propelling the European diagnostics market's ongoing expansion.

Market Segmentation:

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Others

Segmentation 3: by Country

  • Germany
  • U.K.
  • Spain
  • Italy
  • France
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe mass spectrometry and chromatography market consists of various public and few private companies. Key players in the Europe mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Tecan Group Ltd.
  • Merck KGaA
  • Chromsystems Instruments & Chemicals GmbH
  • RECIPE Chemicals + Instruments GmbH
  • SENTINEL CH. SpA

Table of Contents

Executive Summary

Scope and Definition

1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.2 Utilization of Automated Sample Preparation Technologies
  • 1.3 Opportunity Assessment of Key Trends
  • 1.4 Product Benchmarking
  • 1.5 Regulatory Landscape
    • 1.5.1 Regulatory Framework in Europe
      • 1.5.1.1 Recommendations for Diagnostic Approval

2 Region

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 By Product Type
    • 2.3.5 By Application Type
    • 2.3.6 U.K.
      • 2.3.6.1 By Product Type
      • 2.3.6.2 By Application Type
    • 2.3.7 Germany
      • 2.3.7.1 By Product Type
      • 2.3.7.2 By Application Type
    • 2.3.8 France
      • 2.3.8.1 By Product Type
      • 2.3.8.2 By Application Type
    • 2.3.9 Italy
      • 2.3.9.1 By Product Type
      • 2.3.9.2 By Application Type
    • 2.3.10 Spain
      • 2.3.10.1 By Product Type
      • 2.3.10.2 By Application Type
    • 2.3.11 Rest-of-Europe
      • 2.3.11.1 By Product Type
      • 2.3.11.2 By Application Type

3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

  • 3.1 Competitive Landscape
    • 3.1.1 Partnerships, Alliances, and Business Expansions
    • 3.1.2 New Offerings
    • 3.1.3 Mergers and Acquisitions
    • 3.1.4 Regulatory Approvals
  • 3.2 Key Strategies and Development
  • 3.3 Company Competition Matrix
  • 3.4 Company Share Analysis
  • 3.5 Company Profiles
    • 3.5.1 Tecan Group Ltd.
      • 3.5.1.1 Overview
      • 3.5.1.2 Top Products
      • 3.5.1.3 Top Competitors
      • 3.5.1.4 Top Customers
      • 3.5.1.5 Key Personnel
      • 3.5.1.6 Analyst View
    • 3.5.2 Merck KGaA
      • 3.5.2.1 Overview
      • 3.5.2.2 Top Products
      • 3.5.2.3 Top Competitors
      • 3.5.2.4 Top Customers
      • 3.5.2.5 Key Personnel
      • 3.5.2.6 Analyst View
    • 3.5.3 Chromsystems Instruments & Chemicals GmbH.
      • 3.5.3.1 Overview
      • 3.5.3.2 Top Products
      • 3.5.3.3 Top Competitors
      • 3.5.3.4 Top Customers
      • 3.5.3.5 Key Personnel
      • 3.5.3.6 Analyst View
    • 3.5.4 RECIPE Chemicals + Instruments GmbH
      • 3.5.4.1 Overview
      • 3.5.4.2 Top Products
      • 3.5.4.3 Top Competitors
      • 3.5.4.4 Top Customers
      • 3.5.4.5 Key Personnel
      • 3.5.4.6 Analyst View
    • 3.5.5 SENTINEL CH. SpA
      • 3.5.5.1 Overview
      • 3.5.5.2 Top Products
      • 3.5.5.3 Top Competitors
      • 3.5.5.4 Top Customers
      • 3.5.5.5 Key Personnel
      • 3.5.5.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
  • Figure 2: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 5: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 6: EU IVD Regulation
  • Figure 7: U.K. Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 8: Germany Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 9: France Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 10: Italy Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 11: Spain Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 12: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 13: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
  • Figure 14: New Offerings, January 2015- June 2024
  • Figure 15: Mergers and Acquisitions, January 2015- June 2024
  • Figure 16: New Offerings, January 2015- June 2024
  • Figure 17: Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 18: Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
  • Figure 19: Data Triangulation
  • Figure 20: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Europe Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
  • Table 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 5: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 6: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 7: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 8: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 9: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 10: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 11: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 12: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 13: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 14: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 15: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 16: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 17: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 18: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 19: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 20: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 21: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 22: France Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 23: France Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 24: France Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 25: France Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 26: France Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 27: France Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 28: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 29: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 30: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 31: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 32: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 33: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 34: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 35: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 36: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 37: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 38: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 39: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 40: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 41: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 42: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 43: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 44: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 45: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 46: Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024